Session Details

JSNM Oral 1:Oncology 1: Breast

Thu. Nov 13, 2025 9:00 AM - 10:10 AM JST
Thu. Nov 13, 2025 12:00 AM - 1:10 AM UTC
Room 2(1F, Exhibition Hall 2 A, Kyoto International Exhibition Hall 'Miyako Messe')
座長:三宅 可奈江(京都大学大学院医学研究科 放射線医学講座(画像診断学・核医学))、川端 和奈(兵庫県立尼崎総合医療センター 放射線診断科)

[1-MO1-1]Association between ESR1 gene mutation and18F-FES PET uptake in ER-positive breast cancer

Yuki Hoda1,2、Tomohiko Yamane1、Michio Senda1、Mariko Tokiwa3、Sayaka Takebe3、Nina Odan3、Yuri Oyama3、Eiji Suzuki3 (1.Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan、2.Department of Diagnostic and Interventional Radiology, Nara Medical University, Kashirhara, Japan、3.Department of Breast Surgery, Kobe City Medical Center General Hospital, Kobe, Japan)

[1-MO1-2]Association of18F-FES PET/MRI uptake with estradiol levels in ER-positive breast cancer

Kanae Miyake1、Yoichi Shimizu1、Masahiro Kawashima2、Koji Itagaki3、Shunsuke Yuge4、Yurika Kitano1、Sumika Yasumura1、Masako Kataoka5、Norikazu Masuda2、Koya Nakatani1、Yuji Nakamoto1 (1.Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine Kyoto University, Kyoto, Japan、2.Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan、3.Division of Clinical Radiology Service, Kyoto University Hospital , Kyoto, Japan、4.Tenri Hospital, Nara, Japan、5.Preemptive Medicine and Lifestyle-related Disease Research Center , Kyoto University Hospital, Kyoto, Japan)

[1-MO1-3]Dedicated breast (db) PET and MRI findings in follow-up of dbPET-detected breast cancer

Masako Kataoka1、Kanae Miyake2、Masahiro Yakami1、Maya Honda1,2、Hanako Shimizu3、Tomomi Nobashi1,2、Ryusuke Nakamoto1,2、Yasuhide Takeuchi4、Kei Ishii3、Norikazu Masuda3、Yuji Nakamoto2 (1.Preemptive Medicine and Lifestyle-related Disease Research Center , Kyoto University Hospital、2.Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan、3.Department of Breast Surgery, Kyoto University, Kyoto, Japan、4.Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan)

[1-MO1-4]Breast glucose metabolism in patients with breast cancer using multiparametric 18F-FDG PET

Atsushi Shimizu、Yu Iwabuchi、Maho Kurihara、Yoshiki Owaki、Ryosuke Sakurai、Masahiro Jinzaki (Department of Radiology, Keio University School of Medicine, Tokyo, Japan)

[1-MO1-5]Additional value of FES PET/CT in detecting bone metastases from ER-positive breast cancer

Hyunjin Kim1、Kanae Miyake1、Yoichi Shimizu1、Masahiro Kawashima2、Shunsuke Yuge3、Yurika Kitano1、Sumika Yasumura1、Masako Kataoka4、Norikazu Masuda2、Koya Nakatani1、Yuji Nakamoto1 (1.Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine , Kyoto, Japan、2.Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan、3.Tenri Hospital, Nara, Japan、4.Preemptive Medicine and Lifestyle-related Disease Research Center , Kyoto University Hospital, Kyoto, Japan)

[1-MO1-6]Prediction of NAC response in breast cancer: comparison of dbPET and whole-body PET/CT

Yukiko Tokuda1、Yuka Fujita1、Masahiro Yanagawa1、Akinori Hata1、Daiki Nishigaki1、Shuhei Doi1、Kazuki Yamagata1、Tomomi Fujii2、Atsuya Okada3、Kenzo Shimazu4、Noriyuki Tomiyama1 (1.Department of Radiology, The University of Osaka, Osaka, Japan、2.Department of Pathology, The University of Osaka, Osaka, Japan、3.MIクリニック、4.Department of Breast and Endocrine Surgery, The University of Osaka, Osaka, Japan)

[1-MO1-7]A case of disruption of normal lymphatic flow construct by sentinel lymphnode scintigraphy

Ayano Ishiyama1、Reiko Ideguchi2、Ryo Toya1、Takashi Kudo2 (1.Department of Radiological Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan、2.Department of Radioisotope Medicine Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan)